Extracorporeal carbon dioxide removal for acute hypercapnic respiratory failure
In the past, the only treatment of acute exacerbations of obstructive diseases with hypercapnic respiratory failure refractory to medical treatment was invasive mechanical ventilation (IMV). Considerable technical improvements transformed extracorporeal techniques for carbon dioxide removal in an at...
| Autores: | , , |
|---|---|
| Tipo de recurso: | artículo |
| Fecha de publicación: | 2019 |
| País: | España |
| Institución: | Universitat Autònoma de Barcelona |
| Repositorio: | Dipòsit Digital de Documents de la UAB |
| Idioma: | inglés |
| OAI Identifier: | oai:ddd.uab.cat:253310 |
| Acceso en línea: | https://ddd.uab.cat/record/253310 https://dx.doi.org/urn:doi:10.1186/s13613-019-0551-6 |
| Access Level: | acceso abierto |
| Palabra clave: | COPD Asthma ECCOR Invasive mechanical ventilation Noninvasive mechanical ventilation |
| Sumario: | In the past, the only treatment of acute exacerbations of obstructive diseases with hypercapnic respiratory failure refractory to medical treatment was invasive mechanical ventilation (IMV). Considerable technical improvements transformed extracorporeal techniques for carbon dioxide removal in an attractive option to avoid worsening respiratory failure and respiratory acidosis, and to potentially prevent or shorten the duration of IMV in patients with exacerbation of COPD and asthma. In this review, we will present a summary of the pathophysiological rationale and evidence of ECCOR in patients with severe exacerbations of these pathologies |
|---|